Inhibition of the tonic contraction in the treatment of erectile dysfunction

Bibliography

• NO AUTHORS LISTED: National Institute of Health consensus development panel on impotence. JAMA 270:83–90.
   Google Scholar
• JONLER M, MOON T, BRANNAN W, STONE NN, HEISEY D, BRUSKEWITZ RC: The effect of age, ethnicity and geographical location on impotence and quality of life. Br j Ural. (1995) 75:651–655.
   PubMedGoogle Scholar
• FELDMAN HA, GOLDSTEIN I, HATZICHRISTOU DG, KRANE RJ, MCKINLAY JB: Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. j Ural. (1994) 151:54–61.
   PubMed Web of Science ®Google Scholar
• SCHMIDT MH, SCHMIDT HS: The ischiocavernosus and bulbospongiosusmuscles in mammalian penile rigidity. Sleep (1993) 16:171–183.
   PubMed Web of Science ®Google Scholar
• ANDERSSON KE, STIEF CG: Neurotransmission and the contraction and relaxation of penile erectile tissues. World Ural. (1997) 15:14–20.
   PubMed Web of Science ®Google Scholar
• BOHR DF: Electrolytes and smooth muscle contraction. Pharmacy]. Rev (1964) 16:85–111.
   PubMed Web of Science ®Google Scholar
• BERRIDGE MJ, IRVINE RF: Inositol phosphates and cell signalling. Nature (1989) 341:197–205.
   PubMed Web of Science ®Google Scholar
• COLBURN JC, MICHNOFF CH, HSU LC, SLAUGHTER CA, KAMM KE, STULL JT: Sites phosphorylated in myosin light chain in contracting smooth muscle. j Biol. Chem. (1988) 263:19166–19173.
   PubMedGoogle Scholar
• ALLEN BG, WALSH MP: The biochemical basis of the regulation of smooth-muscle contraction. Trends Biochem. Sci. (1994) 19:362–368.
   PubMedGoogle Scholar
• •A very well-documented review of the pathways and agents that regulate the erectile response.
   Google Scholar
• ANDERSSON KE: Pharmacology of penile erection. Pharmacy]. Rev (2001) 53:417–450.
   PubMed Web of Science ®Google Scholar
• SIMONSEN U, PRIETO D, HERNANDEZ M, SAENZ DE TEJADA I, GARCIA-SACRISTAN A: Adrenoceptor-mediated regulation of the contractility in horse penile resistance arteries. j Vase. Res. (1997) 34:90–102.
   PubMed Web of Science ®Google Scholar
• GUPTA S, MORELAND RB, YANG S, GALLANT CM, GOLDSTEIN I, TRAISH A: The expression of functional postsynaptic a2-adrenoceptors in the corpus cavernosum smooth muscle. Br Pharmacy] (1998) 123:1237–1245.
   PubMedGoogle Scholar
• WINGARD CJ, LEWIS R, MILLS TM: Erection and NO override the vasoconstrictive effect of a-adrenergic stimulation in the rat penile vasculature. bit .j Impot. Res. (2001) 13:212–220.
   PubMedGoogle Scholar
• TRAISH AM, GUPTA S, TOSELLI P, DE TEJADA IS, GOLDSTEIN I, MORELAND RB: Identification of aradrenergic receptor subtypes in human corpus cavernosum tissue and in cultured trabecular smooth muscle cells. Receptor (1995) 5:145–157.
   PubMedGoogle Scholar
• TRAISH AM, MORELAND RB, HUANG YH, GOLDSTEIN I: Expression of functional a2-adrenergic receptor subtypes in human corpus cavernosum and in cultured trabecular smooth muscle cells. Recept. Signal Transduct. (1997) 7:55–67.
   PubMedGoogle Scholar
• ANDERSSON KE, WAGNER G: Physiology of penile erection. Physiol. Rev. (1995) 75:191–236.
   PubMed Web of Science ®Google Scholar
• SATO M, KAWATANI M: Effects of noradrenaline on cytosolic concentrations of Ca() in cultured corpus cavernosum smooth muscle cells of the rabbit. NeuroscL Lett. (2002) 324:89–92.
   PubMedGoogle Scholar
• BECKER AJ, UCKERT S, STIEF CG etal.:Cavernous and systemic plasma levels of norepinephrine and epinephrine during different penile conditions in healthy men and patients with erectile dysfunction. Urology (2002) 59:281–286.
   Google Scholar
• YANAGISAWA M, KURIHARA H, KIMURA S, GOTO K, MASAKI T: A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels. Hypertens. Suppl (1988) 6:S188–S191.
   Google Scholar
• ARAI H, HORI S, ARAMORI I, OHKUBO H, NAKANISHI S: Cloning and expression of a cDNA encoding an endothelin receptor. Nature (1990) 348:730–732.
   PubMed Web of Science ®Google Scholar
• SAKURAI T, YANAGISAWA M, TAKUWA Y et al.: Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature (1990) 348:732–735.
   PubMed Web of Science ®Google Scholar
• HOLMQUIST E KIRKEBY HJ, LARSSON B, FORMAN A, ALM E, ANDERSSON KE: Functional effects, binding sites and immunolocalization of endothelin-1 in isolated penile tissues from man and rabbit. j Pharmacol Exp. Ther. (1992) 261:795–802.
   PubMed Web of Science ®Google Scholar
• SAENZ DE TEJADA I, CARSON MR DE LAS MORENAS A, GOLDSTEIN I, TRAISH AM: Endothelin: localization, synthesis, activity, and receptor types in human penile corpus cavernosum. Am. Physiol (1991) 261:H1078–H1085.
   Google Scholar
• DAI Y, POLLOCK DM, LEWIS RL, WINGARD CJ, STOPPER VS, MILLS TM: Receptor-specific influence of endothelin-1 in the erectile response of the rat. Am. j Physiol Regul Integr. Comp. Physiol (2000) 279:R25–R30.
   Google Scholar
• HOLMQUIST E ANDERSSON KE, HEDLUND H: Actions of endothelin on isolated corpus cavernosum from rabbit and man. Acta Physiol Scand. (1990) 139:113–122.
   PubMedGoogle Scholar
• KIFOR I, WILLIAMS GH, VICKERS MA, SULLIVAN MP, JODBERT P, DLUHY RG: Tissue angiotensin II as a modulator of erectile function. I. Angiotensin peptide content, secretion and effects in the corpus cavernosum. j Ural (1997) 157:1920–1925.
   Google Scholar
• PARK JK, KIM SZ, KIM SH, PARK YK, CHO KW: Renin angiotensin system in rabbit corpus cavernosum: functional characterization of angiotensin II receptors. Ural. (1997) 158:653–658.
   PubMedGoogle Scholar
• BECKER AJ, UCKERT S, STIEF CG et al: Plasma levels of angiotensin II during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction. Urology (2001) 58:805–810.
   PubMed Web of Science ®Google Scholar
• HARTSHORNE DJ, ITO M, ERDODI F: Myosin light chain phosphatase: subunit composition, interactions and regulation. Muscle Res. Cell Moth. (1998) 19:325–341.
   PubMed Web of Science ®Google Scholar
• FURCHGOTT RE ZAWADZKI JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 288:373–376.
   PubMed Web of Science ®Google Scholar
• PALMER RIVI, FERRIGE AG, MONCADA S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 327:524–526.
   PubMedGoogle Scholar
• VANHOUTTE PM, MOMBOULI JV: Vascular endothelium: vasoactive mediators. Frog. Cardiovasc. Dis. (1996) 39:229–238.
   PubMed Web of Science ®Google Scholar
• SULLIVAN ME, THOMPSON CS, DASHWOOD MR et al: Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc. Res. (1999) 43:658–665.
   Google Scholar
• ANDERSSON KE, PERSSON K: The L-arginine/nitric oxide pathway and non-adrenergic, noncholinergic relaxation of the lower urinary tract. Gen. Pharmacol. (1993) 24:833–839.
   PubMedGoogle Scholar
• HEDLUND P, ALM P, ANDERSSON KE: NO synthase in cholinergic nerves and NO-induced relaxation in the rat isolated corpus cavernosum. Br. J. Pharmacol (1999) 127:349–360.
   PubMed Web of Science ®Google Scholar
• ANDERSSON KE: Pathways for relaxationof detrusor smooth muscle. Adv. Exp. Med. Biol. (1999) 462:241–252.
   PubMed Web of Science ®Google Scholar
• BURNETT AL: Role of nitric oxide in thephysiology of erection. Biol. Reprod. (1995) 52:485–489.
   PubMed Web of Science ®Google Scholar
• BOOLELL M, ALLEN MJ, BALLARD SA et al.: Sildenafil: an orally active Type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Irm j _Lomat. Res. (1996) 8:47–52.
   Google Scholar
• STIEF CG, UCKERT S, BECKER AJ, TRUSS MC, JONAS U: The effect of the specific phosphodiesterase (PDE) inhibitors on human and rabbit cavernous tissue in vitro and in vivo. j Ural (1998) 159:1390–1393.
   PubMed Web of Science ®Google Scholar
• SAUZEAU V, LE JEUNE H, CARIO-TOUMANIANTZ C: Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. j Biol. Chem. (2000) 275:21722–21729.
   PubMed Web of Science ®Google Scholar
• SAENZ DE TEJADA I: Molecular mechanisms for the regulation of penile smooth muscle contractility. Int. I Impot. Res. (2002) 14 (Supp1.1):S6–S10.
   Google Scholar
• LUNDBERG JM: Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol. Rev (1996) 48:113–178.
   PubMed Web of Science ®Google Scholar
• VAZIRI ND, OVEISI F, DINGY: Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Irm (1998) 53:1748–1754.
   PubMed Web of Science ®Google Scholar
• BESWICK RA, ZHANG H, MARABLE D, CATRAVAS JD, HILL WD, WEBB RC: Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension (2001) 37:781–786.
   PubMed Web of Science ®Google Scholar
• BIVALACQUA TJ, HELLSTROM WJ, KADOWITZ PJ, CHAMPION HC: Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Int. I Impot. Res. (2002) 14:204.
   Google Scholar
• DE NUCCI G, THOMAS R, D' ORLEANS-JUSTE P et al: Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Nati Acad. Sci. USA (1988) 85:9797–9800.
   PubMed Web of Science ®Google Scholar
• ARI G, VARDI Y, HOFFMAN A, FINBERG JP: Possible role for endothelins in penile erection. Eur. j Pharmacol. (1996) 307:69–74.
   PubMedGoogle Scholar
• COMITER CV, SULLIVAN MP, YALLA SV, KIFOR I: Effect of angiotensin II on corpus cavernosum smooth muscle in relation to nitric oxide environment: in vitro studies in canines. Int. I Impot. Res. (1997) 9:135–140.
   PubMedGoogle Scholar
• TEIXEIRA CE, MORENO RA, FERREIRA U et al.: Pharmacological characterization of kinin-induced relaxation of human corpus cavernosum. Br. I Ural (1998) 81:432–436.
   PubMedGoogle Scholar
• PORST H: The rationale for prostaglandin El in erectile failure: a survey of worldwide experience. I Ural (1996) 155:802–815.
   Google Scholar
• MEHATS C, ANDERSEN CB, FILOPANTI M, JIN SL, CONTI M: Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling. Trends Endocrinol Metab. (2002) 13:29–35.
   PubMed Web of Science ®Google Scholar
• DAIL WG, GALLOWAY B, BORDEGARAY J: NADPH diaphorase innervation of the rat anococcygeus and retractor penis muscles. Neurosci. Lett. (1993) 160:17–20.
   PubMedGoogle Scholar
• HEDLUND E ALM E EKSTROM P et al:Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum.Br j Pharmacol (1995) 116:2258–2266.
   PubMedGoogle Scholar
• MONTORSI F, GUAZZONI G, RIGATTI P, POZZA G: Pharmacological management of erectile dysfunction. Drugs (1995) 50:465–479.
   PubMed Web of Science ®Google Scholar
• MILLS TM, REILLY CM, LEWIS RW: Androgens and penile erection: a review. Andra] (1996) 17:633–638.
   PubMed Web of Science ®Google Scholar
• HART BL, WALLACH SJ, MELESE-D'HOSPITAL PY: Differences in responsiveness to testosterone of penile reflexes and copulatory behavior of male rats. Harm. Behav. (1983) 17:274–283.
   PubMed Web of Science ®Google Scholar
• GRAY GD, SMITH ER, DAVIDSON JM:Hormonal regulation of penile erection in castrated male rats. Physiol. Behav. (1980) 24:463–468.
   PubMedGoogle Scholar
• MILLS TM, LEWIS RW, STOPPER VS: Androgenic maintenance of inflow and veno-occlusion during erection in the rat. Biol. Reprod. (1998) 59:1413–1418.
   PubMed Web of Science ®Google Scholar
• REILLY CM, STOPPER VS, MILLS TM: Androgens modulate the a-adrenergic responsiveness of vascular smooth muscle in the corpus cavernosum. I Andra] (1997) 18:26–31.
   PubMedGoogle Scholar
• DEFEO TT, MORGAN KG: Calcium-force relationships as detected with aequorin in two different vascular smooth muscles of the ferret. I Physiol (1985) 369:269–282.
   PubMedGoogle Scholar
• SOMLYO A1 SOMLYO AV: Signal transduction and regulation in smooth muscle. Nature (1994) 372:231–236.
   PubMed Web of Science ®Google Scholar
• •An excellent overall review which demonstrates the importance of the RhoA/Rho-kinase calcium-sensitisation pathway in smooth muscle physiology.
   Google Scholar
• NISHIMURA J, MORELAND S, AHN HY, KAWASE T, MORELAND RS, VAN BREEMEN C: Endothelin increases myofilament Ca2+ sensitivity in a-toxin-permeabilized rabbit mesenteric artery. Circ. Res. (1992) 71:951–959.
   PubMedGoogle Scholar
• LINDER AE, BENDHACK LM: Endothelin- 1-induced contraction is impaired in the tail artery of renal hypertensive rats. Vase. Pharmacol (2002) 39:77–82.
   PubMedGoogle Scholar
• HIRATA K, KIKUCHI A, SASAKI T et al: Involvement of Rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J. Biol. Chem. (1992) 267:8719–8722.
   PubMed Web of Science ®Google Scholar
• SOMLYO A1 SOMLYO AV: Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol (2000) 522\(Pt2):177–185.
   Google Scholar
• SOMLYO A1 SOMLYO AV: From pharmacomechanical coupling to G protein and myosin phosphatase. Acta Physiol Scam/. (1998) 164:437–448.
   PubMedGoogle Scholar
• AMANO M, FUKATA Y, KAIBUCHI K: Regulation and functions of Rho-associated kinase. Exp. Cell Res. (2000) 261:44–51.
   PubMed Web of Science ®Google Scholar
• KIMURA K, ITO M, AMANO M et al: Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science (1996) 273:245–248.
   PubMed Web of Science ®Google Scholar
• PFITZER G, ARNER A: Involvement of small GTPases in the regulation of smooth muscle contraction. Acta Physiol Scam/. (1998) 164:449–456.
   PubMedGoogle Scholar
• KLONER RA, BROWN M, PRISANT LM, COLLINS M: Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Sildenafil Study Group. Am. I Hypertens. (2001) 14:70–73.
   PubMed Web of Science ®Google Scholar
• JEREMY JY, BALLARD SA, NAYLOR AM, MILLER MA, ANGELINI GD: Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro. Br. J. Ural (1997) 79:958–963.
   PubMedGoogle Scholar
• TRAISH A, GUPTA S, GALLANT C, HUANG YH, GOLDSTEIN I: Phentolamine mesylate relaxes penile corpus cavernosum tissue by adrenergic and non-adrenergic mechanisms. Int. I Impot. Res. (1998) 10:215–223.
   PubMed Web of Science ®Google Scholar
• PADMA-NATHAN H, GOLDSTEIN I, KLIMBERG I, COOGAN C, AUERBACH S, LAMMERS P: Long-term safety and efficacy of oral phentolamine mesylate (Vasomax) in men with mild to moderate erectile dysfunction. Int. I Impot. Res. (2002) 14:266–270.
   PubMed Web of Science ®Google Scholar
• BECKER AJ, STIEF CG, MACHTENS Set al: Oral phentolamine as treatment for erectile dysfunction. I Ural (1998) 159:1214–1216.
   Google Scholar
• UGARTE E HURTADO-COLL A: Comparison of the efficacy and safety of sildenafil citrate (Viagra) and oral phentolamine for the treatment of erectile dysfunction. Int. I Impot. Res. (2002) 14\(Suppl. 2):S48–S53.
   Google Scholar
• GIULIANO E RAMPIN O: a-receptors in the central nervous system and its effects on erection. I Andra] (1999) 20:683–687.
   PubMedGoogle Scholar
• DE TEJADA IS, GARVEY DS, SCHROEDER JD et al: Design and evaluation of nitrosylated a-adrenergic receptor antagonists as potential agents for the treatment of impotence. I Pharmacol Esp. Ther. (1999) 290:121–128.
   PubMed Web of Science ®Google Scholar
• STEERS WD, MCCONNELL J, BENSON GS: Some pharmacologic effects of yohimbine on human and rabbit penis. Ural (1984) 131:799–802.
   PubMedGoogle Scholar
• FILIPPI S, LUCONI M, GRANCHI S et al.: Endothelium-dependency of yohimbine-induced corpus cavernosum relaxation. Int. I Impot. Res. (2002) 14:295–307.
   PubMed Web of Science ®Google Scholar
• TELOKEN C, RHODEN EL, SOGARI P, DAMBROS M, SOUTO CA: Therapeutic effects of high dose yohimbine hydrochloride on organic erectile dysfunction. J Ural (1998) 159:122–124.
   PubMed Web of Science ®Google Scholar
• KUNELIUS P, HAKKINEN J, LUKKARINEN O: Is high-dose yohimbine hydrochloride effective in the treatment of mixed-type impotence? A prospective, randomized, controlled double-blind crossover study. Urology (1997) 49:441–444.
   PubMedGoogle Scholar
• LEBRET T, HERVE JM, GORNY P, WORCEL M, BOTTO H: Efficacy and safety of a novel combination of L-arginine glutamate and yohimbine hydrochloride: a new oral therapy for erectile dysfunction. Eur. Ural. (2002) 41:608–613.
   PubMed Web of Science ®Google Scholar
• KREGE S, GOEPEL M, SPERLING H, MICHEL MC: Affinity of trazodone for human penile al- and a2-adrenoceptors. EN 'Ili (2000) 85:959–961.
   Google Scholar
• COSTABILE RA, SPEVAK M: Oral trazodone is not effective therapy for erectile dysfunction: a double-blind, placebo-controlled trial. ..J. Ural. (1999) 161:1819–1822.
   PubMed Web of Science ®Google Scholar
• ENZLIN P, VANDERSCHUEREN D, BONTE L, VANDERBORGHT W, DECLERCQ G, DEMYTTENAERE K: Trazodone: a double-blind, placebo-controlled, randomized study of its effects in patients with erectile dysfunction without major organic findings. Int. I Impot. Res. (2000) 12:223–228.
   PubMed Web of Science ®Google Scholar
• BARDIN ED, KRIEGER JN: Pharmacological priapism: comparison of trazodone- and papaverine-associated cases. Int. Ural. Nephrol (1990) 22:147–152.
   PubMedGoogle Scholar
• KIM NN, DHIR V, AZADZOI KM, TRAISH AM, FLAHERTY E, GOLDSTEIN I: Pilot study of the endothelin-A receptor selective antagonist BMS-193884 for the treatment of erectile dysfunction. I Andra (2002) 23:76–83.
   PubMedGoogle Scholar
• FOGARI R, ZOPPI A: Effects of antihypertensive therapy on sexual activity in hypertensive men. Cun: Hypertens. Rep. (2002) 4:202–210.
   PubMedGoogle Scholar
• LLISTERRI JL, LOZANO VIDAL JV, AZNAR VICENTE J et al.: Sexual dysfunction in hypertensive patients treated with losartan. Am. j Med. Sci (2001) 321:336–341.
   Google Scholar
• TRAISH AM, MORELAND RB, GALLANT C, HUANG YH, GOLDSTEIN I: G-protein-coupled receptor agonists augment adenylyl cyclase activity induced by forskolin in human corpus cavernosum smooth muscle cells. Recept. Signal Transduct. (1997) 7:121–132.
   PubMedGoogle Scholar
• LINET OI, OGRINC FG: Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group. N Engl. I Med. (1996) 334:873–877.
   PubMed Web of Science ®Google Scholar
• HEATON JP, LORDING D, LIU SN et al.: Intracavernosal alprostadil is effective for the treatment of erectile dysfunction in diabetic men. Int. I Impot. Res. (2001) 13:317–321.
   PubMed Web of Science ®Google Scholar
• ANGULO J, CUEVAS P, MONCADA I et al.: Rationale for the combination of PGEO and S-nitroso-glutathione to induce relaxation of human penile smooth muscle. Pharmacol Exp. Ther. (2000) 295:586–593.
   PubMedGoogle Scholar
• ANGULO J, CUEVAS E LA FUENTE JM et al.: Regulation of human penile smooth muscle tone by prostanoid receptors. Br Pharmacol (2002) 136:23–30.
   Google Scholar
• NEHRA A, BLUTE ML, BARRETT DM, MORELAND RB: Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int. I Impot. Res. (2002) 14\(Suppl. 1):538–542.
   Google Scholar
• KIM NN, HUANG Y, MORELAND RB, KWAK SS, GOLDSTEIN I, TRAISH A: Cross-regulation of intracellular cGMP and cAMP in cultured human corpus cavernosum smooth muscle cells. Mal Cell. Biol. Res. Commun. (2000) 4:10–14.
   PubMedGoogle Scholar
• GOLDSTEIN I, PAYTON TR, SCHECHTER PJ: A double-blind, placebo-controlled, efficacy and safety study of topical gel formulation of 1% alprostadil (Topiglan) for the in-office treatment of erectile dysfunction. Urology (2001) 57:301–305.
   PubMed Web of Science ®Google Scholar
• SHIRAI M, MAKI A, TAKANAMI M et al.: Content and distribution of vasoactive intestinal polypeptide (VIP) in cavernous tissue of human penis. Urology (1990) 35:360–363.
   PubMed Web of Science ®Google Scholar
• GU J, POLAK JM, LAZARIDES M etal.:Decrease of vasoactive intestinal polypeptide (VIP) in the penises from impotent men. Lancet (1984) 2:315–318.
   Google Scholar
• SAZOVA O, KADIOGLU A, GURKAN L et al.: Intracavernous administration of SIN-1 + VIP in an in vivo rabbit model for erectile function. 'Ili I Impot. Res. (2002) 14:44–49.
   PubMedGoogle Scholar
• SEO la, KIM SC, JUN IO, OH MM, LEE MY: Synergistic effects of sildenafil on relaxation of rabbit and rat cavernosal smooth muscles when combined with various vasoactive agents. EN 'Ili (2001) 88:596–601.
   Google Scholar
• SANDHU D, CURLESS E, DEAN J et al: A double-blind, placebo-controlled study of intracavernosal vasoactive intestinal polypeptide and phenotolamine mesylate in a novel auto-injector for the treatment of non-psychogenic erectile dysfunction. Int. Impot. Res. (1999) 11:91–97.
   PubMed Web of Science ®Google Scholar
• MCMAHON CG: A pilot study of the role of intracavernous injection of vasoactive intestinal peptide (VIP) and phentolamine mesylate in the treatment of erectile dysfunction. 'Ili I Impot. Res. (1996) 8:233–236.
   PubMedGoogle Scholar
• KIELY EA, BLOOM SR, WILLIAMS G: Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents. Br. J. Ural. (1989) 64:191–194.
   PubMedGoogle Scholar
• BIVALACQUA TJ, CHAMPION HC, ABDEL-MAGEED AB, KADOWITZ PJ, HELLSTROM WJ: Gene transfer of prepro-calcitonin gene-related peptide restores erectile function in the aged rat. Biol. Reprod. (2001) 65:1371–1377.
   PubMed Web of Science ®Google Scholar
• STIEF CG, WETTERAUER U, SCHAEBSDAU FH, JONAS U: Calcitonin gene-related peptide: a possible role in human penile erection and its therapeutic application in impotent patients. I Ural. (1991) 146:1010–1014.
   Google Scholar
• TRUSS MC, BECKER AJ, THON WF et al.: Intracavernous calcitonin gene-related peptide plus prostaglandin El: possible alternative to penile implants in selected patients. Eur. Ural. (1994) 26:40–45.
   PubMed Web of Science ®Google Scholar
• DJAMILIAN M, STIEF CG, KUCZYK M, JONAS U: Followup results of a combination of calcitonin gene-related peptide and prostaglandin El in the treatment of erectile dysfunction. I Ural. (1993) 149:1296–1298.
   Google Scholar
• UEHATA M, ISHIZAKI T, SATOH H et al.: Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature (1997) 389:990–994.
   PubMed Web of Science ®Google Scholar
• REES RW, ZIESSEN T, RALPH DJ, KELL P, MONCADA S, CELLEK S: Human and rabbit cavernosal smooth muscle cells express Rho-kinase. Impot. Res. (2002) 14:1–7.
   PubMed Web of Science ®Google Scholar
• CHITALEY K, WINGARD CJ, WEBB RC et al.: Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway. Nat. Med. (2001) 7:119–122.
   PubMed Web of Science ®Google Scholar
• ••The first demonstration of the importanceof the RhoA/Rho-kinase pathway in the erectile response.
   Google Scholar
• REES RW, RALPH DJ, ROYLE M, MONCADA S, CELLEK S: Y-27632, an inhibitor of Rho-kinase, antagonizes noradrenergic contractions in the rabbit and human penile corpus cavernosum. BE Pharmacol. (2001) 133:455–458.
   Google Scholar
• CHITALEY K, BIVALACQUA TJ, CHAMPION HC et al: Adeno-associated viral gene transfer of dominant negative RhoA enhances erectile function in rats. Biochem. Biophys. Res. Commun. (2002) 298:427–432.
   PubMed Web of Science ®Google Scholar
• MILLS TM, CHITALEY K, LEWIS RW, WEBB RC: Nitric oxide inhibits RhoA/Rho-kinase signaling to cause penile erection. Eur. j Pharmacol. (2002) 439:173–174.
   PubMed Web of Science ®Google Scholar
• •These studies support the hypothesis that an important action of NO leading to erection is the inhibition of the RhoA/Rho-kinase pathway.
   Google Scholar
• CHITALEY K, WEBB RC: Nitric oxide induces dilation of rat aorta via inhibition of Rho-kinase signaling. Hypertension (2002) 39:438–442.
   PubMedGoogle Scholar
• WINGARD CJ, JOHNSON JA, HOLMES A, PRIKOSH A: Improved erectile function following Rho-kinase inhibition in a rat castrate model of erectile dysfuntion. Am. j Physiol. Regul. Integr. Comp. Physiol. (2003). [Electronically published ahead of print].
   Google Scholar
• CHITALEY K, WEBB RC, DORRANCE AM, MILLS TM: Decreased penile erection in DOCA-salt and stroke prone-spontaneously hypertensive rats. Int. _Twat. Res. (2001) 13\(Suppl. 5):516–520. Affiliation
   Google Scholar